Stay updated on IMGN632 in BPDCN Clinical Trial
Sign up to get notified when there's something new on the IMGN632 in BPDCN Clinical Trial page.

Latest updates to the IMGN632 in BPDCN Clinical Trial page
- ChecktodayChange DetectedA site-wide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check7 days agoChange DetectedThe footer revision marker changes from v3.7.1 to v3.7.2 on the forbidden-access page.SummaryDifference0.2%

- Check14 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0; the page continues to show a 403 error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the usual study content, indicating the record is blocked from public access. This access restriction replaces the study details with an error page, reflecting a site-level access issue rather than a data update.SummaryDifference19%

- Check49 days agoChange DetectedResults Posted entry added with detailed efficacy and safety outcomes for BPDCN and related diseases. Locations section updated to 29 sites, including new entries such as University of Alabama at Birmingham.SummaryDifference5%

- Check56 days agoChange DetectedThe page revision label was updated to v3.6.6, signaling a small update to the page rather than changes to study data.SummaryDifference0.0%

Stay in the know with updates to IMGN632 in BPDCN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMGN632 in BPDCN Clinical Trial page.